Skip to main content
OpenTrials

Clinical trial condition

Serotonin Syndrome

Explore clinical trials studying Serotonin Syndrome. Study availability and eligibility vary by location and protocol.

22 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Serotonin Syndrome trial results

Completed

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome

NCT01104415

Conditions
Carcinoid Syndrome, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +1 more
Locations
  • Lexicon Investigational Site Bad Berka, Germany
  • Lexicon Investigational Site Berlin, Germany
  • Lexicon Investigational Site Halle, Germany
  • Lexicon Investigational Site Lübeck, Germany
View Trial Details
Completed

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

NCT00853047

Conditions
Carcinoid Syndrome, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +1 more
Locations
  • Hematology Oncology Services of Arkansas Little Rock, Arkansas, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • St. Francis Medical Group Oncology and Hematology Specialists Indianapolis, Indiana, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)

NCT01677910

Conditions
Carcinoid Syndrome, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +1 more
Locations
  • Lexicon Investigational Site Mobile, Alabama, United States
  • Lexicon Investigational Site Palo Alto, California, United States
  • Lexicon Investigational Site San Francisco, California, United States
  • Lexicon Investigational Site Orlando, Florida, United States
View all 75 locations
View Trial Details
Completed

Telotristat Etiprate for Carcinoid Syndrome Therapy

NCT02063659

Conditions
Carcinoid Syndrome, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +1 more
Locations
  • Lexicon Investigational Site Stanford, California, United States
  • Lexicon Investigational Site Orlando, Florida, United States
  • Lexicon Investigational Site Iowa City, Iowa, United States
  • Lexicon Investigational Site Lexington, Kentucky, United States
View all 50 locations
View Trial Details
Completed

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

NCT02299089

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +17 more
Locations
  • Hospices Civils de Lyon Bron, France
  • CHU Rouen, Hôpital Charles Nicolle Rouen, France
  • Abteilung: Klinische Studien Bad Berka, Germany
  • Charité Campus Virchow Klinikum Berlin, Germany
View Trial Details
Completed

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

NCT00088595

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Univ. Of Iowa Holden Cancer Center Iowa City, Iowa, United States
  • Louisiana State University Medical Center New Orleans, Louisiana, United States
View Trial Details

Related conditions